Amid the continued run-up on the headline Nifty50 index and stock-specific fundamentals, some of the bluechips including ...

Tariffs are adding pressure in a volatile market where recession looms but inflation may stay muted. Check out how I’m ...

The U.S. healthcare sector experienced a turbulent trading session on April 17, 2025, as UnitedHealth’s UNH earnings disappointment sent ripples through insurer stocks. However, strong gains in ...

Pfizer has been paying dividends for 35 years and raising them for 14 years. Read more to see whether PFE stock is a buy.

The company’s sales and profits have grown at a CAGR of 14.8% and 6.5% respectively over the last five years, reaching Rs 6.8 bn and Rs 0.6 bn in FY24. Its RoE and RoCE have averaged 23% and 31%, ...

The year 2025 is witnessing a significant expansion of the Medical Info Systems industry, fueled by new federal policies and ...

Tata Elxsi stock rose despite a 13% fall in Q4 profit. Morgan Stanley has a underweight call on the Tata Group stock.

The Board of Directors has recommended a final dividend of Rs 75 per equity share (750%) for FY25, subject to shareholder ...

Bursa Malaysia opened higher but later slipped as market sentiment turned cautious. At 9.19 am, the FTSE Bursa Malaysia KLCI ...

Socioeconomic factors likely contribute to racial and ethnic disparities in health care utilization among patients with ...

Read about Turn/River Capital's acquisition of IT management software company SolarWinds for approximately $4.4 billion.

Motilal Oswal midcap fund has been the best performing with a staggering annualised return of over 36 per cent in a 5-year ...